21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat

Molecular Pharmacology

Volumn 52, Issue 4, 1997, Pages 749-753

  Vicent, G P ^a   Monteserin M C ^a   Veleiro, A S ^a   Burton, G ^a   Lantos, C P ^a   Galigniana, M D ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; 15BETA,16BETA METHYLENEMEXRENONE; 21 HYDROXY 6,19 OXIDOPROGESTERONE; ALDOSTERONE; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID ANTAGONIST; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PROGESTERONE; STEROID; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; ENZYME INDUCTION; KIDNEY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM RETENTION;

EID: 0030761842     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.4.749     Document Type: Article

References (26)

1. Hollemberg, S. M., C. Weinberger, E. S. Ong, G. Cereli, A. Oro, R. Lebo, E. B. Thompson, M. G. Rosenfeld, and R. M. Evans. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (Lond.) 318:635-641 (1985).
2. Forman, B. M., and R. M. Evans. Nuclear hormone receptors activate direct, inverted, and everted repeats. Ann. N. Y. Acad. Sci. 761:29-37 (1995).
3. Lantos, C. P., G. Burton, A. Roldán, M. C. Damasco, and A. Aragonés. Structure-activity relationship in certain glucocorticoids and mineralocorticoids, in Physiopathology of Endocrine Diseases and Mechanisms of Hormone Action (R. J. Soto, A. de Nicola, and J. Blaquier, eds.). Alan R. Liss, New York, 477-494 (1981).
4. Duax, W. L., V. Cody, J. F. Griffin, D. C. Rohrer, and C. M. Weeks. Molecular conformation and protein binding affinity of progestins. J. Toxicol. Environ. Health 4:205-227 (1978).
5. Burton, G., M. D. Galigniana, S. de Lavallaz, A. L. Brachet-Cota, E. M. Sproviero, A. A. Ghini, C. P. Lantos, and M. C. Damasco. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids. Mol. Pharmacol. 47:535-543 (1995).
6. Arriza, J., C. Weinberg, G. Cerelli, T. Glaser, B. Handelin, D. Housman, and R. Evans. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science (Washington D. C.) 237:268-275 (1987).
7. Teutsch, G., F. Nique, G. Lemoine, F. Bouchoux, E. Cérède, D. Gofflo, and D. Philibert. General structure-activity correlations of antihormones. Ann. N. Y. Acad. Sci. 761:5-28 (1995).
8. 3H-ZK91587: a new synthetic, highly specific ligand for mineralocorticoid receptor determination. J. Steroid Biochem. 23(suppl): 19S (1985).
9. Sutanto, W., and E. R. de Kloet. ZK91587: a novel synthetic antimineralocorticoid displays high affinity for corticosterone (Type I) receptors in the rat hippocampus. Life Sci 43:1537-1543 (1988).
10. Antiprogestins/antiglucocorticoids, in Endocrinology at Roussel-Udaf. 64 (1993).
11. Spitz, I. M., and C. W. Bardin. Mefiprestone (RU486): a modulator of progestin and glucocorticoid action. N. Engl. J. Med. 329:404-412 (1993).
12. Brachet-Cota, A. L., and G. Burton. An improved preparation of 11,19-oxidopregn-4-ene-3,20-dione and 6,19-oxidopregnan-4-ene-3,11,20-trione. Z. Naturforsch. Teil B Anorg. Chem. Org. Chem. 45:711-715 (1990).
13. Veleiro, A. S., M. V. Nevado, M. C. Monteserín, and G. Burton. Syntheses of 21-hydroxy-11,19-oxidopregn-4-ene-3,20-dione and 21-hydroxy-6,19-oxidopregn-4-ene-3,20-dione. Steroids 60:268-271 (1995).
14. Galigniana, M. D., G. P. Vicent, G. Burton, and C. P. Lantos. Features of the shuttle pair 11β-hydroxyprogesterone/11-ketoprogesterone. Steroids 62:358-364 (1997).
15. Galigniana, M. D. Stability study on renal type I mineralocorticoid receptor. Life Sci. 59:511-521 (1996).
16. Jordan, V. C., and C. J. Dix. Effect of oestradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division. J Steroid Biochem. 11:285-291 (1979).
17. Krisman, C. A method for the colorimetric estimation of glycogen with iodine. Anal. Biochem. 4:17-23 (1962).
18. Fry, J., C. Jones, P. Webkin, and J. Bridges. The enzymatic isolation of adult rat hepatocytes in a functional and viable state. Anal. Biochem. 71:341-350 (1976).
19. Granner, D., and G. Tomkins. Metabolism of amino acids and amines: tyrosine amino-transferase. Methods Enzymol. 17:633-637 (1975).
20. Gomez-Sanchez, C. E., and E. P. Gomez-Sanchez. RU26988: a new tool for the study of the mineralocorticoid receptor. Endocrinology 113:1004-1009 (1983).
21. Funder, J. W. Glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 43:389-394 (1992).
22. Galigniana, M. D., G. P. Vicent, C. P. Lantos, and G. Burton. Ligand properties of 11,19-oxidoprogesterone: a preliminary report. Ann. Assoc. Química Argentina 81:333-340 (1993).
23. Krozowski, Z. S. and J. F. Funder. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. USA 80:6056-6060 (1983).
24. Kraujelis, K., A. Ulinskaite, and V. Meilus. Transcortin in rat kidney: subcellular distribution of transcortin-synthesizing polyribosomes. J. Steroid Biochem. Mol. Biol. 38:43-47 (1991).
25. Jensen, E. V. Steroid hormone antagonists: an overview. Ann. N. Y. Acad. Sci. 761:1-1 (1995).
26. Hendry, L. B., C. K. Chu, M. L. Rosser, J. A. Copland, J. C. Wood, and V. B. Mahesh. Design of novel antiestrogens. J. Steroid Biochem. Mol. Biol. 49:269-280 (1994).